Related Experiment Videos
Artificial intelligence approaches for rational drug design and discovery
Włodzisław Duch1, Karthikeyan Swaminathan, Jarosław Meller
1Department of Informatics, Nicolaus Copernicus University, Grudziadzka 5, Toruń, Poland. wduch@is.umk.pl
Current Pharmaceutical Design
|May 17, 2007
Summary
Machine learning and artificial intelligence (AI) are vital for drug discovery, enabling pattern recognition and quantitative structure-activity relationship (QSAR) studies. This review highlights interpretable AI methods and their applications in drug design and biomedical research.
Area of Science:
- Computational Chemistry
- Bioinformatics
- Artificial Intelligence
Background:
- Pattern recognition, machine learning (ML), and artificial intelligence (AI) are increasingly crucial in rational drug design.
- These computational approaches are essential for screening candidate molecules and understanding quantitative structure-activity relationships (QSAR).
Purpose of the Study:
- To provide an overview of fundamental ML and AI concepts and methodologies.
- To emphasize AI methods that offer intuitive interpretation and problem-specific insights.
- To discuss the integration of computational and experimental approaches in drug discovery.
Main Methods:
- Review of basic concepts and methodologies in machine learning and artificial intelligence.
- Discussion of AI methods applicable to molecular docking, virtual screening, and QSAR studies.
- Exploration of interpretable AI techniques for gaining insights into drug design problems.
Main Results:
- AI and ML methods are pivotal for efficient drug candidate identification and QSAR analysis.
- Interpretable AI facilitates a deeper understanding of structure-activity relationships and molecular interactions.
- Representative applications of AI in docking, screening, and QSAR studies are presented.
Conclusions:
- AI and ML are transforming drug discovery by enhancing rational design, screening, and QSAR.
- The integration of computational and experimental methods, guided by interpretable AI, is a growing trend.
- AI approaches hold significant promise for advancing broader biomedical research and therapeutic development.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...